Advertisement
American Cancer Society
Subscribe to American Cancer Society

The Lead

Double Mastectomy Doesn't Boost Survival for Most

September 3, 2014 8:39 am | by LINDSEY TANNER, AP Medical Writer | News | Comments

Removing both breasts to treat cancer affecting only one side doesn't boost survival chances for most women, compared with surgery that removes just the tumor, a large study suggests. The results raise concerns about riskier, potentially unnecessary operations that increasing numbers of women are choosing.

DNA Alternative to Pap Smear Sparks Medical Debate

April 15, 2014 1:41 pm | by MATTHEW PERRONE, AP Health Writer | News | Comments

A high-tech screening tool for cervical cancer is facing pushback from more than a dozen U.S....

Lethal Numbers

January 22, 2014 3:20 pm | by Mike Auerbach, Editor in Chief | Blogs | Comments

Recently, I was listening to a radio news broadcast discussing the 50th anniversary...

Historic Smoking Report Marks 50th Anniversary

January 6, 2014 9:03 am | by MIKE STOBBE, AP Medical Writer | News | Comments

Fifty years ago, ashtrays seemed to be on every table and desk. Athletes and even Fred...

View Sample

FREE Email Newsletter

Study Says Many Lung Cancer Tumors Prove Harmless

December 10, 2013 8:55 am | by LINDSEY TANNER, AP Medical Writer | News | Comments

Harmless lung cancer? A provocative study found that nearly 1 in 5 lung tumors detected on CT scans are probably so slow-growing that they would never cause problems. The analysis suggests the world's No. 1 cause of cancer deaths isn't as lethal as doctors once thought.

Cancer Society Hits 100 as US Cancer Rate Falls

May 22, 2013 8:08 am | by MIKE STOBBE,AP Medical Writer | News | Comments

The American Cancer Society — one of the nation's best known and influential health advocacy groups — is 100 years old this week. Back in 1913 when it was formed, cancer was a lesser threat for most Americans. The biggest killers then were flu, pneumonia, tuberculosis, and stomach bugs. At a time when average life expectancy was 47, few lived long enough to get cancer.

Report: Death Rates From Cancer Still Inching Down

January 8, 2013 3:14 am | by LAURAN NEERGAARD,AP Medical Writer | News | Comments

WASHINGTON (AP) — Death rates from cancer are continuing to inch down, researchers reported Monday.  

Advertisement

Global Cancer Cases Could Rise 75% by 2030

June 4, 2012 4:14 am | by MARIA CHENG,AP Medical Writer | News | Comments

LONDON (AP) — Global cancer cases are projected to rise 75 percent by 2030, in part because many other diseases are being stamped out and more developing countries are adopting Western lifestyles linked to cancer, international health experts reported.  

Annual Cancer Screening Tests Urged Less And Less

October 19, 2011 4:29 am | by MARILYNN MARCHIONE,AP Chief Medical Writer | News | Comments

Annual cancer tests are becoming a thing of the past. New guidelines out Wednesday for cervical cancer screening have experts at odds over some things, but they are united in the view that the common practice of getting a Pap test every year is too often and probably doing more harm than good.

Cancer Death Rate Gap Widens Based on Education

June 17, 2011 5:09 am | by MIKE STOBBE,AP Medical Writer | News | Comments

ATLANTA (AP) — The gap in cancer death rates between college graduates and those who only went to high school is widening, the American Cancer Society reported Friday.

Weighing Cancer Risks, from Cellphones to Coffee

June 16, 2011 4:57 am | by MARILYNN MARCHIONE,AP Medical Writer | News | Comments

You're sitting in a freshly drywalled house, drinking coffee from a plastic foam cup and talking on a cellphone. Which of these is most likely to be a cancer risk?

What's in a Cigarette? FDA to Study Ingredients

January 19, 2010 4:05 am | News | Comments

MICHAEL FELBERBAUM AP Tobacco Writer RICHMOND, Va. (AP) — The Food and Drug Administration is working to lift the smokescreen clouding the ingredients used in cigarettes and other tobacco products.

Advertisement

FDA Debates Tougher Cancer Warning on Tanning Beds

January 19, 2010 3:20 am | News | Comments

LAURAN NEERGAARD AP Medical Writer WASHINGTON (AP) — Just as millions head to tanning beds to prepare for spring break, the Food and Drug Administration will be debating how to toughen warnings that those sunlamps pose a cancer risk. Yes, sunburns are particularly dangerous.

Radient Pharmaceuticals Signs Research Collaboration Agreement With CeTeCancer

October 15, 2009 4:42 am | News | Comments

Radient Pharmaceuticals Corporation, a US-based pharmaceutical company, announced today it has entered into a collaboration agreement through its wholly owned subsidiary AMDL Diagnostics, Inc.

NJ Lawmaker Seeks to Limit Electronic Cigarettes

October 7, 2009 4:59 am | News | Comments

VICTOR EPSTEIN Associated Press Writer PARAMUS, N.J. (AP) — A northern New Jersey lawmaker wants to extend current limits on the availability of tobacco cigarettes to apply to electronic cigarettes to prevent them from being embraced by children.

Study: Lung Cancer Drug Iressa Works For Some

August 20, 2009 4:49 am | News | Comments

MIKE STOBBE AP Medical Writer ATLANTA (AP) — Four years after the government severely restricted its use, the lung cancer drug Iressa may be poised to make a comeback: A study concludes it can slow the deadly disease better than standard chemotherapy in certain patients.

FDA Approves Avastin Plus Interferon-Alfa for Metastatic Renal Cell Carcinoma

August 3, 2009 4:31 am | News | Comments

Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the FDA approved Avastin(R) (bevacizumab) plus interferon-alfa for people with metastatic renal cell carcinoma, the most common type of kidney cancer.

Advertisement

Prostate Cancer Vaccine Extends Survival in Study

April 28, 2009 11:49 am | News | Comments

MARILYNN MARCHIONE AP Medical Writer CHICAGO (AP) — An experimental treatment added four months to the lives of men with advanced prostate cancer in a study that tested an entirely new approach to fighting the disease, doctors reported Tuesday. Dendreon Corp.

FDA Approves New Drug for Deadly Kidney Cancer

March 30, 2009 12:23 pm | News | Comments

WASHINGTON (AP) — Federal health officials are approving a drug from Novartis to treat patients whose kidney cancer has returned after treatment with older drugs.

Huge Study Boosts Disappointment On Multivitamins

February 10, 2009 4:54 am | News | Comments

By LINDSEY TANNER AP Medical Writer CHICAGO (AP) — The largest study ever of multivitamin use in older women found the pills did nothing to prevent common cancers or heart disease. the eight-year study in 161,808 postmenopausal women echoes recent disappointing vitamin studies in men.

Pfizer Names New Head of Clinical Development and Medical Affairs for Its Oncology Business Unit

October 23, 2008 12:37 pm | News | Comments

Pfizer has named Mace L. Rothenberg, M.D. as Senior Vice President, Clinical Development and Medical Affairs for its Oncology Business Unit. Dr.

FDA Grants IND for Pro-Pharmaceuticals' DAVANAT to Treat Breast Cancer Patient

August 28, 2008 11:15 am | News | Comments

Pro-Pharmaceuticals, Inc. has been granted an Investigational New Drug (IND) application by the FDA for use of DAVANAT in combination with 5-FU to treat a breast cancer patient at the Brown Cancer Center in Louisville, Kentucky.

Innovative Strategy For Packaging Of Frozen Dendritic Cell Vaccine

April 5, 2006 8:58 am | Product Releases | Comments

View of cleanroom #1 in new vaccine manufacturing facility at Baylor Institute for Immunology Research. By Nicolas Taquet Technical Director of Baylor Institute for Immunology ResearchTechnical Director of ODC Therapy, Inc. Melanoma is a form of skin cancer.

FDA Accepts SuperGen's New Drug Application for Filing

March 29, 2004 5:55 am | Product Releases | Comments

DUBLIN, CA (March 29, 2004) – SuperGen Inc., based here, said Friday that the Food & Drug Administration (FDA) has officially accepted the Orathecin(TM) (rubitecan) capsules' New Drug Application (NDA) for filing.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading